BofA raised the firm’s price target on Incyte (INCY) to $124 from $121 and keeps a Buy rating on the shares. The Q1 report showed typical seasonality, but FY26 guidance was reaffirmed and the firm is “encouraged” by continued growth of the core business and significant progress across the pipeline, the analyst tells investors.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on INCY:
